Study: Common pain relievers linked to increased breast cancer risk

06/1/2005 | USA Today

New research suggests that long-term ibuprofen or aspirin may in fact increase the risk of breast cancer, contrary to previous findings. The study of 114,460 teachers found that women who took ibuprofen daily for at least five years were about 50% more likely to be diagnosed with breast cancer, and women who took aspirin daily for at least five years were 80% more likely to develop breast cancers not sensitive to estrogen or progesterone.

View Full Article in:

USA Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health